Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 10Unknown 6Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Anemia, Iron-Deficiency 2Plexosarcoma 1Lymphoproliferative Disorders 1Gastrointestinal Stromal Tumors 1Anemia 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × ferric carboxymaltose × Clear all
NCT01100879 2022-05-09

AOC-MM

Vifor Pharma

Phase 4 Terminated
3 enrolled
Classical hematologyLymphoid

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡